News

Safe Supply and Origin Therapeutics Receive Conditional Approval for Listing on the CSE

Vancouver, British Columbia--(Newsfile Corp. - September 11, 2023) - Safe Supply Streaming Co. Ltd. ("Safe Supply" or the "Company") and…

1 year ago

Cloud DX Announces Closing of $3,546,000 Private Placement of Secured Convertible Debentures, and Amendments to Existing Unsecured Convertible Debentures and Warrant Repricing

KITCHENER, ON / ACCESSWIRE / September 11, 2023 / Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX) (OTCQB:CDXFF), is…

1 year ago

Healthcare Leadership Education Provider Generation Leader Announces the Launch of Five New Courses, Limited Time Tuition Discount

MIDDLESEX, UK / ACCESSWIRE / September 11, 2023 / Generation Leader, the only leadership course provider certified by the 3…

1 year ago

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability

Conservative care private practice owners can leverage Breakthrough's exclusive marketing campaigns to promote Enovis™ Corporation's innovative therapeutic technologies directly to…

1 year ago

Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,…

1 year ago

Sona’s ‘THT’ Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Halifax, Nova Scotia--(Newsfile Corp. - September 11, 2023) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona")…

1 year ago

NervGen Pharma to Present at 2023 International Spinal Research Trust Network Meeting

Vancouver, British Columbia--(Newsfile Corp. - September 11, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a…

1 year ago

Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference

Click here to access webcast replayTop line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer…

1 year ago

Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research

PARIS, FRANCE / ACCESSWIRE / September 11, 2023 / Owkin and Tribun Health announce a strategic partnership to advance the…

1 year ago